5WKT image
Deposition Date 2017-07-25
Release Date 2017-12-13
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5WKT
Title:
3.2-Angstrom In situ Mylar structure of bovine opsin at 100 K
Biological Source:
Source Organism:
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.29
R-Value Work:
0.27
R-Value Observed:
0.27
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Rhodopsin
Gene (Uniprot):RHO
Chain IDs:A
Chain Length:348
Number of Molecules:1
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Transducin Galpha peptide
Chain IDs:B
Chain Length:11
Number of Molecules:1
Biological Source:Bos taurus
Peptide-like Molecules
PRD_900006
Primary Citation
High-throughput in situ X-ray screening of and data collection from protein crystals at room temperature and under cryogenic conditions.
Nat Protoc 13 260 292 (2018)
PMID: 29300389 DOI: 10.1038/nprot.2017.135

Abstact

Protein crystallography has significantly advanced in recent years, with in situ data collection, in which crystals are placed in the X-ray beam within their growth medium, being a major point of focus. In situ methods eliminate the need to harvest crystals, a previously unavoidable drawback, particularly for often small membrane-protein crystals. Here, we present a protocol for the high-throughput in situ X-ray screening of and data collection from soluble and membrane-protein crystals at room temperature (20-25°C) and under cryogenic conditions. The Mylar in situ method uses Mylar-based film sandwich plates that are inexpensive, easy to make, and compatible with automated imaging, and that show very low background scattering. They support crystallization in microbatch and vapor-diffusion modes, as well as in lipidic cubic phases (LCPs). A set of 3D-printed holders for differently sized patches of Mylar sandwich films makes the method robust and versatile, allows for storage and shipping of crystals, and enables automated mounting at synchrotrons, as well as goniometer-based screening and data collection. The protocol covers preparation of in situ plates and setup of crystallization trials; 3D printing and assembly of holders; opening of plates, isolation of film patches containing crystals, and loading them onto holders; basic screening and data-collection guidelines; and unloading of holders, as well as reuse and recycling of them. In situ plates are prepared and assembled in 1 h; holders are 3D-printed and assembled in ≤90 min; and an in situ plate is opened, and a film patch containing crystals is isolated and loaded onto a holder in 5 min.

Legend

Protein

Chemical

Disease

Primary Citation of related structures